These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 1471338)
1. [Immunoglobulins in virological research and in the prevention of infections]. Pshenichnov VA; Krasnianskiĭ VP; Mikhaĭlov VV Vopr Virusol; 1992; 37(4):178-80. PubMed ID: 1471338 [No Abstract] [Full Text] [Related]
2. A focus on humoral immunity to viral infections. Woodland DL Viral Immunol; 2012 Dec; 25(6):441. PubMed ID: 23216306 [No Abstract] [Full Text] [Related]
3. [Antiviral humanized and human monoclonal antibodies]. Lashkevich VA Vopr Virusol; 2011; 56(5):4-8. PubMed ID: 22171470 [TBL] [Abstract][Full Text] [Related]
5. [Immunity of viruses and the effectiveness of vaccines. Mechanism of protective immune response of hosts to viruses]. Shimizu K Nihon Rinsho; 1987 Oct; 45(10):2211-7. PubMed ID: 2452259 [No Abstract] [Full Text] [Related]
6. [Immunity of viruses and the effectiveness of vaccines. Mode of virus infections and effectiveness of vaccines]. Shishido A Nihon Rinsho; 1987 Oct; 45(10):2218-24. PubMed ID: 3448260 [No Abstract] [Full Text] [Related]
8. Antibodies, viruses and vaccines. Burton DR Nat Rev Immunol; 2002 Sep; 2(9):706-13. PubMed ID: 12209139 [TBL] [Abstract][Full Text] [Related]
9. Instabilities in multiserotype disease models with antibody-dependent enhancement. Billings L; Schwartz IB; Shaw LB; McCrary M; Burke DS; Cummings DA J Theor Biol; 2007 May; 246(1):18-27. PubMed ID: 17270219 [TBL] [Abstract][Full Text] [Related]
10. [Indications for passive immunotherapy in infectious diseases]. Baumgartner JD Schweiz Med Wochenschr; 1987 Jan; 117(3):84-90. PubMed ID: 3823822 [TBL] [Abstract][Full Text] [Related]
11. Methods for evaluating the protective activity of intravenous immunoglobulins for neonatal pathogens: entanglement or encouragement? Baker CJ; Edwards MS Pediatrics; 1990 Dec; 86(6):995-7. PubMed ID: 2123537 [No Abstract] [Full Text] [Related]
12. Role of secretory antibodies in the defence against infections. Brandtzaeg P Int J Med Microbiol; 2003 Apr; 293(1):3-15. PubMed ID: 12755363 [TBL] [Abstract][Full Text] [Related]
14. [Immunoglobulins and rules of passive-active prophylaxis]. Bucholc B Przegl Epidemiol; 2003; 57(2):391-7. PubMed ID: 12910611 [TBL] [Abstract][Full Text] [Related]
15. Oral immunization and secretory immunity to viruses. Ogra PL; Leibovitz EE; Zhao-Ri G Curr Top Microbiol Immunol; 1989; 146():73-81. PubMed ID: 2659276 [No Abstract] [Full Text] [Related]
16. The prevention of virus disease. 1948. Francis T Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Aug; 100(2 Suppl):S22-6. PubMed ID: 16037789 [No Abstract] [Full Text] [Related]
17. Oral immunotherapy with yolk antibodies to prevent infections in humans and animals. Larsson A; Carlander D Ups J Med Sci; 2003; 108(2):129-40. PubMed ID: 14649324 [TBL] [Abstract][Full Text] [Related]
18. [Virus infections]. Seige G Med Monatsschr Pharm; 1993 Aug; 16(8):239-43. PubMed ID: 8377715 [No Abstract] [Full Text] [Related]
19. Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Pantaleo G; Harari A Nat Rev Immunol; 2006 May; 6(5):417-23. PubMed ID: 16622477 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of neutralization of animal viruses. Dimmock NJ J Gen Virol; 1984 Jun; 65 ( Pt 6)():1015-22. PubMed ID: 6202836 [No Abstract] [Full Text] [Related] [Next] [New Search]